OncoCyte Corp (OCX)
2.73
-0.05
(-1.78%)
USD |
NASDAQ |
May 03, 15:18
OncoCyte Cash from Operations (TTM): -23.32M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.32M |
| September 30, 2023 | -28.41M |
| June 30, 2023 | -37.55M |
| March 31, 2023 | -41.96M |
| December 31, 2022 | -45.57M |
| September 30, 2022 | -42.98M |
| June 30, 2022 | -42.57M |
| March 31, 2022 | -39.38M |
| December 31, 2021 | -35.94M |
| September 30, 2021 | -35.02M |
| June 30, 2021 | -30.04M |
| March 31, 2021 | -28.94M |
| December 31, 2020 | -25.98M |
| September 30, 2020 | -25.14M |
| June 30, 2020 | -23.99M |
| March 31, 2020 | -19.87M |
| December 31, 2019 | -19.72M |
| Date | Value |
|---|---|
| September 30, 2019 | -16.86M |
| June 30, 2019 | -14.50M |
| March 31, 2019 | -15.61M |
| December 31, 2018 | -11.65M |
| September 30, 2018 | -12.54M |
| June 30, 2018 | -13.52M |
| March 31, 2018 | -12.85M |
| December 31, 2017 | -13.38M |
| September 30, 2017 | -12.56M |
| June 30, 2017 | -10.12M |
| March 31, 2017 | -8.645M |
| December 31, 2016 | -7.522M |
| September 30, 2016 | -6.703M |
| June 30, 2016 | -7.055M |
| March 31, 2016 | -6.232M |
| December 31, 2015 | -4.229M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-45.57M
Minimum
Dec 2022
-14.50M
Maximum
Jun 2019
-30.41M
Average
-28.94M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
| Fonar Corp | 15.29M |
| XWELL Inc | -16.07M |
| ProPhase Labs Inc | -11.35M |
| Applied DNA Sciences Inc | -7.592M |
| Veracyte Inc | 44.22M |